BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1890243)

  • 1. Recurrence rates of treated basal cell carcinomas. Part 1: Overview.
    Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Sep; 17(9):713-8. PubMed ID: 1890243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
    Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy.
    Silverman MK; Kopf AW; Gladstein AH; Bart RS; Grin CM; Levenstein MJ
    J Dermatol Surg Oncol; 1992 Jul; 18(7):549-54. PubMed ID: 1624628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.
    Silverman MK; Kopf AW; Bart RS; Grin CM; Levenstein MS
    J Dermatol Surg Oncol; 1992 Jun; 18(6):471-6. PubMed ID: 1592998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of treatment modalities for primary basal cell carcinomas.
    Thissen MR; Neumann MH; Schouten LJ
    Arch Dermatol; 1999 Oct; 135(10):1177-83. PubMed ID: 10522664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas.
    Kedilioglu MA; Bos PG; De Jong K; Noordzij NA; Kibbelaar RE; Lapid O; Mouës CM
    Eur J Surg Oncol; 2018 Jan; 44(1):157-162. PubMed ID: 29198817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate risk score for recurrence of cutaneous basal cell carcinomas.
    Dubin N; Kopf AW
    Arch Dermatol; 1983 May; 119(5):373-7. PubMed ID: 6847215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of basal cell carcinoma of the skin with curettage.
    Reymann F
    Arch Dermatol; 1971 Jun; 103(6):623-7. PubMed ID: 5555850
    [No Abstract]   [Full Text] [Related]  

  • 11. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
    Rigel DS; Torres AM; Ely H
    J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinoma of the skin recurrence rate after different types of treatment. A review.
    Reymann F
    Dermatologica; 1980; 161(4):217-26. PubMed ID: 6997095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage.
    Wagner RF; Cottel WI
    J Am Acad Dermatol; 1987 Dec; 17(6):1047-9. PubMed ID: 3429717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal cell epithelioma. Types, treatment methods, and prognosis.
    Browder JP; Tomsick RS
    Postgrad Med; 1983 Feb; 73(2):161-8. PubMed ID: 6823454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of basal cell carcinoma. Which option is best?
    Goldberg LH; Rubin HA
    Postgrad Med; 1989 Jan; 85(1):57-8, 61-3. PubMed ID: 2911554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma.
    Marghoob A; Kopf AW; Bart RS; Sanfilippo L; Silverman MK; Lee P; Levy E; Vossaert KA; Yadav S; Abadir M
    J Am Acad Dermatol; 1993 Jan; 28(1):22-8. PubMed ID: 8425966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the recurrence rate of basal cell carcinoma.
    Bøgelund FS; Philipsen PA; Gniadecki R
    Acta Derm Venereol; 2007; 87(4):330-4. PubMed ID: 17598036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-curettage in a private dermatological practice.
    Werlinger KD; Upton G; Moore AY
    Dermatol Surg; 2002 Dec; 28(12):1138-42; discussion 1142. PubMed ID: 12472494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Munich method of micrographic surgery for basal cell carcinomas: 5-year recurrence rates with life-table analysis.
    Boztepe G; Hohenleutner S; Landthaler M; Hohenleutner U
    Acta Derm Venereol; 2004; 84(3):218-22. PubMed ID: 15202839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.